Spray-dried formulations offer an attractive delivery system for administration of drug 13 encapsulated into liposomes to the lung, but can suffer from low encapsulation efficiency 14 and poor aerodynamic properties. In this paper the effect of the concentration of the 15 anti-adherent l-leucine was investigated in tandem with the protectants sucrose and 16 trehalose. Two manufacturing methods were compared in terms of their ability to offer small 17 liposomal size, low polydispersity and high encapsulation of the drug indometacin. 18
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Introduction 32
Liposomes are suited to encapsulation of a variety of drugs from small molecular 33 weight compounds to macromolecules and including both hydrophilic and lipophilic entities. 34 This is reflected in the range of therapeutics that have been tested in liposomal 35
formulations including cytotoxic agents [3] ; bronchodilators and anti-asthmatics [4; 5]; 36 antibiotics [6] as well as photosensitizing agents [7] and genetic material [8] [9] [10] . The use of 37 spray drying to produce stable powder formulations for pulmonary administration is 38 attractive since it offers several advantages over the parenteral route [1] . Aerodynamic 39 diameter is a crucial factor in determining deposition of particles in the different sites of the 40 respiratory tract. Particles in the range 1-6 µm are best suited to deposition in the lower 41 airway following inhalation [2]; those with diameters > 6 µm are deposited in the oropharynx, 42
whereas smaller particles (< 1 µm) are exhaled during normal tidal breathing. In addition, 43 fine particle fraction (FPF, the fraction of powder emitted from the inhaler with a particle size 44 ≤5 µm) is a critical parameter to predict the proportion of the emitted dose that can deliver 45 deeply into the lower respiratory system. The Use of liposomes as carriers offers benefits 46 including protection of drug from enzymatic degradation; prolonging retention time and reducing side effects. The effect of disaccharide protectants on the stability of spray dried liposomes has 63 been examined previously [32-34] , while amino acids have been shown to play an 64 important role in improving the aerosol behaviour of spray-dried powders by reducing 65 moisture sorption and surface tension of dried particles [37; 38]; they can also protect 66 proteins against thermal stresses and denaturation [39] . Leucine, in particular, tends to 67 improve powder aerosol properties, this anti-adherent effect has been attributed to its 68 hydrophobic character and surfactant-like properties that allow it to migrate rapidly to the 69 surfaces of the particles during drying [40; 41] and it has been shown to interact well with 70 lipid membranes [42] . Two studies have used leucine in combination with sugars at very 71 high fixed concentrations [43; 44] . To the best of our knowledge, the effect of varying 72 leucine concentration on the spray drying of liposomal systems has not been investigated 73 previously. In this paper we demonstrate the effect of varying concentrations of the 74 anti-adherent L-leucine in combination with optimised concentrations of disaccharides and 75
show for the first time that formulation effects can lead to significant differences in the 76 product characteristics for spray dried liposomes, especially in terms of for sucrose 77 formulations. Furthermore, at higher concentrations leucine increases liposome size. 78
Additionally, we investigated whether switching from the ethanol injection to the 79 proliposome method of liposome preparation affected liposome properties or drug release. 80
Indometacin was chosen as it has been used previously as a model drug in liposomal 81 
Preparation of liposomes by ethanol injection 98
Small unilamellar vesicles (SUV's) were prepared by ethanol injection method followed 99 by sonication in order to reduce liposomal size. Each batch was prepared on a 10g scale. 100 0.02 g Indometacin was dissolved in 0.7 g ethanol (at 57 o C) together with the lipids 101 composed of 1g SPC and 0.115 g cholesterol. Hydration media were prepared by 102 dissolving varying amounts (2.5, 5, 7.5, 10 and 15% w/w) of disaccharides (sucrose or 103 trehalose) in 0.9% NaCl solution. Once the optimum concentration of these protectants 104 had been determined, liposomal dispersions were prepared using various concentrations 105 (0.25, 0.5 and 1% w/w) of L-Leucine added into the hydration medium also containing the 106 optimum concentration of each protectant. The lipid solution was rapidly injected into 107 8.165g of hydration medium at room temperature with stirring. After 2 hr hydration, the 108 prepared liposomal suspension was then submitted to a probe sonication process with a 109 sequence of 40 s of sonication and 20 s of rest in an ice bath to the desired size. In all 110 cases, the initial turbid liposomal suspension was translucent after sonication. Then, the 7 sonicated liposomes were annealed at 4 o C overnight before centrifugation (12,000 rpm, 30 112 min) and diluted 4-fold to give a final lipid concentration of 25 mg/mL of lipid. (c) 5.5-7 min, 100% methanol, flow rate of 1.2 ml/min; (d) 7-9 min, 100% methanol, flow 150 rate of 1.5 ml/min; (e) 9-15 min, 100% methanol, flow rate of 1.5 ml/min; (f) 15-16 min, 9 100% methanol, flow rate of 1 ml/min (g) 16-17 min, 100→85% methanol, flow rate of 1.0 152 ml/min; (h) 17-23 min, 85% methanol, flow rate of 1.0 ml/min. In order to determine 153 encapsulation efficiency (EE %) 50 µL of separate liposome solutions and reconstituted 154 dispersions were applied to a Sephadex G-50 column and eluted with hydration medium. 155
The fractions were diluted with methanol and the concentrations of indometacin were 156 determined by HPLC. Loading efficiency was determined by dividing the encapsulated drug 157 content (µg) by the lipid content (mg). The encapsulation efficiency (EE (%)) of indometacin 158 was determined from the ratio of encapsulated to total drug concentration. 159 160
Water content and thermal analysis of the powders. 161
Thermogravimetric studies were carried out to measure the water content of the 162 spray-dried liposomes using a TGA (Q500, TA instruments). Samples were heated from 20 163 to 25 o C at a scan rate of 10 o C /min. Modulated differential scanning calorimetry (MTDSC) 164 measurements of the dried products were performed on TA Q100 Differential Scanning 165
Calorimeter (Q100, TA Instruments, which had been calibrated for temperature, enthalpy 166 and heat capacity). The product was sealed into a hermetic aluminium pan and after 167 The spray-dried powders were coated with gold in a sputter coater and their surface 172 morphology was observed using a scanning electron microscope (JEOL 6500F field 173 emission scanning electron microscope). 174
Powder particle size analysis 175
The volume mean diameter of spray-dried liposomes was measured by Laser Light 176
Diffraction
Analyzer (HELOS/BR, Sympatec, Clausthal-Zellerfeld, Germany). 177
Approximately 5 mg of powder were suspended in chloroform in a 50 ml glass cuvette and 178 stirred with a magnetic bar at 1000 rpm. A short period of sonication (60 s) at a power of 179 60W (CUVETTE, Sympatec; 8.5 mm diameter ultrasound tip) was applied before sizing [48; 180 49] . A R4 lens was used allowing measurements in the range of 0.45-875 µm. 181
in vitro release of indometacin from liposomes 182
Free drug was removed from the reconstituted liposome suspensions by use of 183 centrifugal filter tubes (Amicon Ultra 15 MW Cut-off 10 KDa, Millipore). 1 ml portions were 184 sealed into dialysis tube (MW cut-off 7 KDa, Thermo Scientific), and added to 50 mL of pH 185 7.4 PBS release medium in a shaking incubator (37° ±0.5 •C, 60 rpm, 25 mm throw; 186
Unitron, Infors HT, Switzerland). 2-ml samples were drawn periodically and the amount of 187 drug release determined using the HPLC method. The release volume was kept constant 188 throughout. 189
Aerodynamic study 190
A twin-stage liquid impinger was used to determine the emitted dose and fine particle 191 
3.1Initial Determination of Optimum Disaccharide and L-leucine concentrations 207

.1 Effect of disaccharide concentration on liposomal size and PI 208
The size change of any liposomes prior to and after spray drying is a critical parameter 209 in the assessment of liposomal stability so this was used as an initial screening parameter 210 in choosing which formulations to take forward to the next step of formulation optimisation. 211
Initially the optimum concentration of either sucrose or trehalose as protectants during the 212 spray drying process was determined. 213
<Figure 1> 214
As shown in Figure 1a , the addition of 2.5% (w/w) sucrose to the hydration medium did 215 not prevent the aggregation and fusion of reconstituted liposomes after spray drying, but 216 increasing the concentration to 5% (w/w) inhibited liposomal size increase prior to spray 217 drying and after reconstitution more effectively. A further increase to 7.5% (w/w) showed no 218 significant change in the PI values. 10% (w/w) Sucrose was more protective still; this was 219 the only formulation containing disaccharide alone that showed no statistical difference in 220 liposomal size after drying. A further increase in concentration to 15% (w/w) resulted in an 221 increase in liposome size. This effect can also be seen by comparing the S F /S I ratios, 222
where is S F is the final liposomal size after rehydration and S I is the initial liposomal size 223 [50] . Previous research into freeze-drying of liposomes demonstrated that solute 224 incorporated by liposome in the presence of lyoprotectant in a mass ratio of sugar: lipid of 225 2:1 could be effectively retained after freeze-drying [51], in the 5% (w/w) sucrose 226 dispersions the mass ratio of sucrose to lipid is close to this ratio. A similar effect was 227 observed when trehalose was used as the protectant (Figure 1b ). However, the protective 228 effect of trehalose was not so good; the addition of 15% (w/w) trehalose dihydrate to the 229 hydration medium did not prevent the liposome size increasing after reconstitution (p < 230 0.05). 231
Effect of disaccharide concentration on recovery rate and water content of 232
spray-dried liposome powders 233
The recovery rate of the spray-dried powders significantly improved when increasing the 234 concentration of protectants from 2.5% (w/w) to 5% (w/w) for both sugars (Figure 2) , 235 although further addition of either disaccharide showed little additional effect. Further, the 236 spray-dried liposomes with trehalose had a much higher recovery rate than those with 237 sucrose, which is ascribed to its higher Tg (101 °C compared with 64 °C for sucrose [36] . 238
The sticky point (Ts) of an amorphous powder is generally considered to lie 10-20 °C above 239
Tg; if the outlet temperature of the dryer surpasses Ts then particle cohesion increases 240
sharply and there may also be increased adhesion to the dryer walls [35] . Because the 241 powder temperature would have been greater than the Tg for the sucrose formulation, the 242 particles would have been more prone to adherence to the walls of the spray-dryer. 243
Increasing the concentration of either protectant reduced the water content of the 244 spray-dried powders (Figure 2 ). Since Tg data are inversely related to water content this 245 would be expected. Based on the results in 3.1.1 and 3.1.2 the formulations containing 10% 246 sucrose and 15% trehalose were selected for further optimisation by addition of the 247 anti-adherent L-leucine. 248 <Figure 2> 249 <Figure 3> 250 
Effect of varying L-leucine concentration 251
Effect of L-leucine concentration on liposomal size 252
Effect of L-leucine concentration on recovery rate and water content
(w/w) trehalose, which exhibited good yields already. L-Leucine did not have a significant 272 effect on the water contents of the powders (Figure 4) 
Effect of Liposome manufacturing method on liposomal size and drug content 281
Once the optimal levels of disaccharide and anti-adherent had been determined, the 282 effects of manufacturing process variables were investigated. Table 1 shows that liposomal 283 size was clearly larger for the formulations prepared by the proliposome method. It has 284 been suggested that the proliposome-prepared liposomes produce multilamellar vesicles 285
[31], while those prepared by the ethanol-injection method are primarily unilamellar, which 286 are more amenable to size reduction under the same sonication conditions. Based on 287 encapsulation efficiency and loading efficiency, the two methods have the same capability 288 to incorporate indometacin. However, lipid loss during the alcohol injection method could 289 not be avoided owing to this process involving injection of lipid solution into hydration 290 medium. It has previously been reported that ethanol concentration is a decisive factor in 291 liposome size reduction using a high-pressure homogenizer, whereby the liposomal size 292 and range decreased with increasing concentration of ethanol [55] . 293
Statistically significant changes were seen between freshly prepared and reconstituted 294 liposomes prepared by the ethanol injection in terms of PI value, encapsulated content and 295 loading efficiency. The small increases in encapsulated content and loading efficiency were 296 attributed to unentrapped drug being reincorporated into the liposomes during 297 reconstitution, as has previously been demonstrated for liposomes prepared using the DRV 298 (dried-rehydrated vesicle) method [56] . Even though the formulation was optimised using 299 the ethanol injection method, excellent encapsulation efficiency in liposomes prepared by 300 the proliposome method was obtained. Dispersions produced using the proliposome 301 method showed small statistically significant reductions in PI values for both formulations, 302 while for the trehalose formulation there was also a small statistically significant reduction in 303 liposomal size after drying. However, the liposomal indometacin content and its loading 304 efficiency did not significantly change during spray drying. In short, while sucrose enabled a 305 better loading efficiency when comparing samples produced by the ethanol injection 306 method; the combination of either 10% (w/w) sucrose and 0.5% (w/w) leucine or 15% (w/w) 307 trehalose and 0.5% (w/w) leucine in the formulations could effectively protect liposomes 308 prepared by either method against spray drying stress. In terms of drug loading and 309 efficiency liposomes prepared by the proliposome method incorporated drug more 310 effectively than those produced using the ethanol-injection method ( Table 1 ). In addition, a dilution effect was observed when comparing loading efficiency of liposomal stock solutions 312 and the final dispersions prepared by the ethanol-injection method, which was attributed to 313 encapsulated drug leaking out of the liposome stock solutions upon dilution as observed by. 
Imaging, size analysis and aerodynamic properties of the spray-dried powders 320
SEM analysis showed that particles of the optimally formulated sucrose powder 321 exhibited a smooth surface (Figure 5a and b) , while the powders containing trehalose were 322 wrinkled (Figure 5d , e and f), which potentially prevents particles from adhering tightly to 323 each other, thus preventing aggregation and lowering the energy required to disperse them 324
[58]. This may explain why the sucrose formulation appeared to contain more aggregates. 325 Furthermore, the fine particle fraction was higher for the trehalose/L-leucine formulation 326 than for that containing sucrose/L-Leucine ( Figure 6) . 327
<Figure 6> 328
Bosquillon et al [59] had reported that the type of sugar incorporated did not affect 329 morphology of the spray-dried powders. The wrinkled surface perhaps can be attributed to 330 the inclusion of additives that alter the surface tension that controls droplet shape during 331 drying as Adler et al [60] demonstrated that surfactant could change the interface viscosity 332 and that consequently, the dried particle morphology also changed. By increasing the ratio 333 of surfactant to other additives, more spherical, smooth particles were obtained. It is 334
proposed that L-leucine at a concentration of 0.5% (w/w) functions as a surfactant. Hence, 335 it is suggested that the ratio of 0.5% (w/w) leucine to 15% (w/w) trehalose is below the 336 critical point of powder morphology conversion between roughness and smoothness and 337 so it tends to exhibit a wrinkled surface. The formulation containing 10%(w/w) sucrose 338 and 0.5% (w/w) exhibited a smoother morphology. To investigate whether this was a 339 concentration effect rather than being specific for trehalose, spray dried liposomes were 340 prepared with a sucrose concentration of 15% (w/w), but these still had smooth surfaces 341 ( Figure 5c and d) , indicating that the wrinkling is not caused by surface tension effects 342 alone. The SEM images also show that the diameters of all the spray dried powders were 343 less than 10µm ( Figure 5 ). Accurate size distribution data are given in Table 2 , which show 344 that all formulations the volume mean diameters were measured to be 3~4 µm with the 345 exception of the formulation containing 10% (w/w) sucrose and 0.5% (w/w) L-leucine, 346 prepared by ethanol injection, which gave a larger diameter of 5.40 µm. This size increase 347 cannot be attributed to hygroscopicity of the sucrose formulations [34] as the water content 348 values for all formulations were similar. Although the sucrose formulations exhibited lower 349
Tg values than the trehalose formulations, as might be expected, there was no significant 350 difference between those obtained for the liposomes prepared by the ethanol injection 351 rather than the proliposome method. The emitted dose and fine particle fraction of 352 spray-dried liposome formulated with trehalose and L-leucine were higher than those 353 formulated with 10% (w/w) sucrose and 0.5% (w/w) L-leucine. (Figure 6 ). Therefore, spray 354 dried liposomes with 15% (w/w) trehalose and 0.5% (w/w) leucine exhibited better aerosol 355 powder performance than those in the presence of 10% (w/w) sucrose and 0.5% (w/w) 356 leucine in terms of emitted dose, aerodynamic diameter and fine particle fraction. 357 <Figure 7> 358
Release of indometacin from reconstituted liposomes 359
Release data for Indometacin from reconstituted liposomes for both optimised 360 formulations using both methods of manufacture are shown in Figure 7 . Diffusion of free 361 indometacin through the dialysis membrane was measured as a control. The release profile 362 of free drug shows over 80% diffusion in 4 hr. Over the same interval, the reconstituted 363 liposomes prepared by the ethanol-injection method released 15.1 % and 16.9% drug 364 (optimised formulations containing sucrose & trehalose respectively) and released ~45% of 365 the encapsulated drug over 24 hr. Those prepared by the proliposome method in the 366 presence of disaccharide (sucrose or trehalose) and leucine exhibited drug release of 367 21.8% and 24.3% in 4 hr and in total released 54.5% and 61.5% over 24 hours respectively 368 ( Figure 7 ). These differences are not significant suggesting that the mode of release is the 369 same for all formulations. The mechanism responsible for the release of drug from the 370 liposomes may be due to diffusion phenomena, degradation effects, or a combination of 371 both processes. To examine the drug release kinetics and mechanism, the release data 372 were fitted to models representing zero-order, first-order, and Higuchi's square root of time 373 and the Korsmeyer-Peppas models ( Table 3) . All systems showed best correlation with the 374
Higuchi model and anomalous (non-Fickian) diffusion (n > 0.5). It is reasonable to 375 propose that this is because the indometacin is located within the phospholipid membrane 376 of the liposomes and must diffuse through in order to be released. 377 378
Conclusions 379
The inclusion of either 10% (w/w) sucrose or 15% (w/w) trehalose dihydrate and 0.5% 380 (w/w) L-leucine protected liposomes prepared by ethanol injection or proliposome method 381 against spray drying stress in terms of size change, polydispersity index, encapsulated 382 drug content and loading efficiency of the reconstituted liposomes. Formulation design was 383 of more importance than the method of liposome manufacture. The method for preparing 384 the liposomes had no effect on the stability or encapsulation efficiency of spray-dried 385 liposomes with optimal protectant and anti-adherent. 386
This paper has demonstrated for the first time that L-leucine should be used with care 387 as an additive for spray dried liposomes in combination with disaccharide. While there was 388 a clear advantage in using this material at an optimum level; at higher concentrations it 389 caused an increase in liposomal size upon rehydration of the spray dried powders that 390 might be attributed to it partitioning into the lipid membrane during drying, causing vesicle 391 21 fusion. This is an area for future research. 392 393 394 Table  1 . The characterization of liposomes prepared by ethanol injection and by proliposome. The hydration buffers were in either a combination of 10% (w/w) sucrose and 0.5% (w/w) L--Leucine or 15% (w/w) trehalose dihydrate and 0.5% (w/w) L--Leucine. * denotes P<0.05 (Mann--Whitney U test) in comparison with the corresponding samples prior to spray--drying. + P<0.05 (Mann--Whitney U test) compared to formulations with the inclusion of trehalose/L--Leucine. Each value represents the mean ± SD (three different batches) and n denotes replicate measurements of each batch. 
Preparative methods
